comparemela.com

Latest Breaking News On - Ramezn eskander - Page 1 : comparemela.com

Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer

Ramez N. Eskander, MD, discusses overall survival data for pembrolizumab plus chemotherapy in advanced/recurrent endometrial cancer.

California
United-states
San-diego
Ramezn-eskander
Reproductive-sciences
San-diego-health
University-of-california
Moores-cancer-center
Advanced-recurrent-endometrial-cancer
Pembrolizumab-plus-chemotherapy

Pembrolizumab Plus Chemo Could Represent a New SOC in Advanced/Recurrent Endometrial Cancer

Ramez N. Eskander, MD, discusses updated data for pembrolizumab plus chemotherapy in patients with advanced/recurrent endometrial cancer.

San-diego
California
United-states
Ramezn-eskander
University-of-california
Moores-cancer-center
San-diego-health
Prescription-drug-user-fee-act

vimarsana © 2020. All Rights Reserved.